Important considerations for drugs, nutritional, and herbal supplements in pediatric solid organ transplant recipients

被引:2
作者
Pilch, Nicole A. [1 ]
Sell, Megan L. [2 ]
McGhee, William [3 ]
Venkataramanan, Raman [4 ]
机构
[1] Med Univ South Carolina, Transplant ICCE, Dept Pharm Practice & Outcomes Sci, Charleston, SC 29425 USA
[2] Med Univ South Carolina, Transplant ICCE, Pediat Solid Organ Transplant & Surg, Charleston, SC 29425 USA
[3] UPMC Childrens Hosp Pittsburgh, Transplantat Ambulatory Care, Pittsburgh, PA USA
[4] UPMC, Thomas Starzl Transplantat Inst, Sch Pharm & Med, Pittsburgh, PA USA
关键词
cyclosporine; dietary supplement; herbal products; immunosuppression; pediatric; tacrolimus; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MYCOPHENOLATE-MOFETIL; RELEASE FORMULATION; GENERIC TACROLIMUS; DOUBLE-BLIND; BIOEQUIVALENCE; ANALGESICS; PROBIOTICS; CONVERSION; STABILITY;
D O I
10.1111/petr.13881
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Pediatric transplant recipients are on multiple prescription and non-prescription drugs. Many patients also use dietary, nutritional, and herbal supplements. This manuscript researched formulations of immunosuppressive drugs currently available and presents information on generic immunosuppressive drugs, commonly used non-prescription medications, dietary supplements, and herbal supplements. Immunosuppressive drugs are available in various formulations. Not all formulations are interchangeable. A number of FDA-approved generic formulations are available commercially in the United States. Generally generic formulations produce similar blood concentration vs time profiles compared to brand name products in adults and are considered to be bioequivalent. NSAID should be avoided in transplant patients due to potential drug interactions and increased risk associated with NSAID use; and appropriate doses of acetaminophen should be used for treatment of pain. Over-the-counter medications, such as guaifenesin and dextromethorphan, antihistamine medications, including diphenhydramine, loratadine, cetirizine, and fexofenadine, can be safely used in pediatric solid organ transplant population. Many safe and effective over-the-counter options exist for stool softening and as laxative. Diarrhea can lead to an increase in calcineurin inhibitor levels. Food can alter the absorption of immunosuppressive drugs. Several herbal products can alter immune status of the patients or alter the blood concentration of immunosuppressive drugs or may produce renal or hepatic toxicities and should be avoided in pediatric transplant recipients. It is important to educate pediatric transplant recipients and their families about not only immunosuppressive drug therapy but also about non-prescription drugs, dietary, and herbal supplement use.
引用
收藏
页数:12
相关论文
共 62 条
  • [1] Comparison of generic tacrolimus and Prograf drug levels in a pediatric kidney transplant program: Brief communication
    Abdulnour, Husam A.
    Araya, Carlos E.
    Dharnidharka, Vikas R.
    [J]. PEDIATRIC TRANSPLANTATION, 2010, 14 (08) : 1007 - 1011
  • [2] Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial
    Alloway, Rita R.
    Vinks, Alexander A.
    Fukuda, Tsuyoshi
    Mizuno, Tomoyuki
    King, Eileen C.
    Zou, Yuanshu
    Jiang, Wenlei
    Woodle, E. Steve
    Tremblay, Simon
    Klawitter, Jelena
    Klawitter, Jost
    Christians, Uwe
    [J]. PLOS MEDICINE, 2017, 14 (11)
  • [3] Mycotoxin Contamination Concerns of Herbs and Medicinal Plants
    Altyn, Iwona
    Twaruzek, Magdalena
    [J]. TOXINS, 2020, 12 (03)
  • [4] [Anonymous], 2006, JOINT COMMISSION SEN
  • [5] [Anonymous], 2018, INF SIM DROPS SIM PA
  • [6] [Anonymous], 2019, AFR OX PACK INS
  • [7] [Anonymous], 2018, ZORTR EV PACK INS
  • [8] [Anonymous], 2015, NEOR CYCL SOFT CAP P
  • [9] [Anonymous], 2016, MYF MYC ACID SOD PAC
  • [10] [Anonymous], 2018, ENV XR PACK INS